Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
EPA Issues Partial Ban On Some Flame Retardant, Fuel and Lubricant Chemicals June 28, 2019 Martha Garcia Add Your Comments Four chemicals commonly used in flame retardants, fuels and lubricants may face a partial ban, due to risks they pose to human health.. The U.S. Environmental Protection Agency (EPA) issued a press release on June 21, announcing a proposed rule (PDF) that would result in a nearly full ban on two chemicals, a partial ban on two other chemicals, and no ban on a fifth chemical. The chemicals in question are referred to as persistent bioaccumulative and toxic substances, or PBTs, including: decabromodiphenyl ether (decaBDE) a flame retardant; phenol isopropylated phosphate 3:1 (PIP 3:1) a flame retardant used in consumer products, lubricant, and hydraulic fluid; 2,4,6-tris(tert-butyl) (2,4,6-TTBP) an additive for fuels and lubricants; pentachlorothiophenol (PCTP) is a chemical used to make rubber pliable; hexachlorobutadiene (HCBD) is used as a solvent and hydraulic, heat transfer or transformer fluid. Do You Know about… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Each of the chemicals are known to have toxic side effects on humans, and to accumulate in the body. DecaBDE may impact human development, have neurological effects, and is carcinogenic. PIP (3:1) can cause harm to the reproductive system, as well as neurological and developmental effects. 2,4,6-TTBP can potentially effect the liver and human development. Research on PCTP has shown side effects to the liver and reproductive system. The proposed rule would prohibit some actions regarding manufacturing, import, processing, and distribution of the chemicals, except for HCBD. The rule also puts into place record keeping regulations. Most uses of the two flame retardants decaBDE and PIP 3:1 are banned under the proposed rules. The ban also prohibits the processing and distribution of 2,4,6-TTBP for use as an oil or lubricant additive and prevents consumer and business uses of the additive. PCTP would be partially banned; with products containing the chemical in concentrations below 1% by weight being the exception. The agency does not plan to take action on HCBD, despite data indicating the chemical negatively effects development and reproduction and is a possible human carcinogen. The chemicals are subject to fast track action under the 2016 revisions to the Toxic Substances Control Act. In 2016, under the Lautenberg Act, the EPA called for a review and expedited action on 10 chemicals, including some PBTs. The action allowed the EPA to forgo conducting risk evaluations and move to risk management instead. The act calls on the agency to address the risk the chemicals pose to human health or the environment and reduce that exposure. The EPA had a deadline to propose a new rule within 3 years of the Lautenberg Act. To that end, the regulation must be finalized within 18 months of issuing the proposal, or by December 2020. Comments on the proposed regulation will be accepted for 60 days. Tags: Cancer, Chemicals, EPA, Flame Retardants, Toxicity More Lawsuit Stories New Bard Hernia Mesh Lawsuits Continue To Be Filed Following Global Settlement April 3, 2025 Food Manufacturers Seek Dismissal of Ultra-Processed Food Childhood Diabetes Lawsuit April 3, 2025 Flavored Vape Restrictions Upheld by Supreme Court April 3, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES New Bard Hernia Mesh Lawsuits Continue To Be Filed Following Global Settlement (Posted: today) In the six months since a Bard hernia mesh settlement agreement was reached, at least two dozen new lawsuits have been brought, as the implants continue to fail and require revision surgery. MORE ABOUT: HERNIA MESH LAWSUITHernia Surgery Malpractice Lawsuit Cleared To Move Forward Over Botched Procedure (03/21/2025)Mediation To Discuss Settling Covidien Hernia Mesh Lawsuits Set for March 31 Through April 4 (03/14/2025)Covidien Hernia Mesh Settlement Talks To Get Underway After Parties Select Mediator Next Week (02/19/2025) Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (Posted: yesterday) As new BioZorb lawsuits continue to be filed over complications with the recalled breast tissue markers, lawyers indicate they are on track for the first of four test cases to go before a jury in September 2025. MORE ABOUT: BIOZORB LAWSUITCourt Clears BioZorb Lawsuit Design Defect Claims Over Recalled Breast Tissue Marker (03/26/2025)Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (03/19/2025)Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025) Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: 2 days ago) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)
New Bard Hernia Mesh Lawsuits Continue To Be Filed Following Global Settlement (Posted: today) In the six months since a Bard hernia mesh settlement agreement was reached, at least two dozen new lawsuits have been brought, as the implants continue to fail and require revision surgery. MORE ABOUT: HERNIA MESH LAWSUITHernia Surgery Malpractice Lawsuit Cleared To Move Forward Over Botched Procedure (03/21/2025)Mediation To Discuss Settling Covidien Hernia Mesh Lawsuits Set for March 31 Through April 4 (03/14/2025)Covidien Hernia Mesh Settlement Talks To Get Underway After Parties Select Mediator Next Week (02/19/2025)
Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (Posted: yesterday) As new BioZorb lawsuits continue to be filed over complications with the recalled breast tissue markers, lawyers indicate they are on track for the first of four test cases to go before a jury in September 2025. MORE ABOUT: BIOZORB LAWSUITCourt Clears BioZorb Lawsuit Design Defect Claims Over Recalled Breast Tissue Marker (03/26/2025)Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (03/19/2025)Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025)
Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: 2 days ago) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)